Patents by Inventor Gisbert Weckbecker

Gisbert Weckbecker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Somatostatin peptides
    Patent number: 6225284
    Abstract: Somatostain analogues comprising the amino acid sequence of the formula (I): -(D/L)Trp-Lys-X1-X2, wherein X1 is a substituted Thr, Ser, Tyr, Glu or Cys residue and X2 is an &agr;-amino acid having an aromatic residue on the C&agr; side chain, or an amino acid unit selected from Dab, Dpr, Dpm, His (Bzl)HyPro, thienyl-Ala, cyclohexyl-Ala and t.-butyl-Ala, the residue Lys of said sequence corresponding to the residue Lys9 of the native somatostatin-14, in free form, in salt form or complexed with a detectable element have interesting pharmacological properties.
    Type: Grant
    Filed: December 29, 1997
    Date of Patent: May 1, 2001
    Assignee: Novartis AG
    Inventors: Rainer Albert, Wilfried Bauer, Christian Bruns, Nagarajan Chandramouli, Ian Lewis, Gisbert Weckbecker
  • Chelated peptides, complexes thereof, pharmaceutical compositions containing them and their use as radiopharmaceuticals
    Patent number: 6183721
    Abstract: Compounds of formula I wherein M is a cation equivalent and A is Phe or Tyr, in free form or in salt form are useful as radiopharmaceuticals when complexed with a radionuclide.
    Type: Grant
    Filed: April 23, 1997
    Date of Patent: February 6, 2001
    Assignee: Novartis AG
    Inventors: Rainer Albert, Christian Bruns, Peter Smith-Jones, Barbara Stolz, Gisbert Weckbecker